Literature DB >> 26488833

Feasibility of a Text Messaging Intervention to Promote Self-Management for Patients Prescribed Oral Anticancer Agents.

Sandra L Spoelstra1, Charles W Given2, Alla Sikorskii2, Constantinos K Coursaris2, Atreyee Majumder2, Tracy DeKoekkoek2, Monica Schueller2, Barbara A Given3.   

Abstract

PURPOSE/
OBJECTIVES: To determine proof of concept of a mobile health (mHealth) intervention delivering text messages (texts) to self-manage among patients prescribed oral anticancer agents (OAs) and to examine preliminary efficacy on symptoms and medication adherence.
DESIGN: A longitudinal randomized, controlled trial.
SETTING: Two community cancer centers in the midwestern United States and a national specialty pharmacy. SAMPLE: 80 adults with cancer who were newly prescribed OAs
.
METHODS: Adherence and symptoms were assessed weekly for 10 weeks in both groups. The intervention group received daily texts for adherence and weekly for symptoms for 21-28 days, and satisfaction with the intervention was assessed
. MAIN RESEARCH VARIABLES: Medication adherence and symptom severity.
FINDINGS: Mean age was 58.5 years (SD = 10.7 years), 48 participants were female, and 48 were Caucasian. Fewer symptoms were found in the intervention group with a moderate effect size. Adherence was higher in the text group using medical record and prescription data (n = 26) with greater relative dose intensity of moderate to large effect size. Regarding acceptability, 57% (83 of 145) of eligible participants consented, 39 of 40 participants completed the entire intervention, 30 participants read texts all of the time, and 34 participants were satisfied with the intervention.
CONCLUSIONS: Proof of concept and preliminary efficacy of an mHealth intervention using texts to promote self-management for patients prescribed OAs was demonstrated. Patients had high satisfaction with the texts, and adherence and symptoms improved after the intervention. IMPLICATIONS FOR NURSING: Texts show promise for patients with cancer who must manage their OAs. Additional research is needed prior to use in practice.

Entities:  

Keywords:  PROMIS; SMS; cancer; mHealth; medication adherence; mobile phone; oral agent; text messaging

Mesh:

Substances:

Year:  2015        PMID: 26488833     DOI: 10.1188/15.ONF.647-657

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  10 in total

1.  Achieving value in mobile health applications for cancer survivors.

Authors:  Sharon Watkins Davis; Ingrid Oakley-Girvan
Journal:  J Cancer Surviv       Date:  2017-03-24       Impact factor: 4.442

2.  Patient Engagement With an Automated Telephone Symptom Management Intervention: Predictors and Outcomes.

Authors:  Alla Sikorskii; Charles W Given; Barbara A Given; Asish Banik; John C Krauss
Journal:  Ann Behav Med       Date:  2020-06-12

3.  Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review.

Authors:  Shoshana M Rosenberg; Keith J Petrie; Annette L Stanton; Lan Ngo; Emma Finnerty; Ann H Partridge
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

4.  Adult Cancer Patient Recruitment and Enrollment into Cell Phone Text Message Trials.

Authors:  Sandra L Spoelstra; Alla Sikorskii; Charles W Given; Constantinos K Coursaris; Atreyee Majumder; Monica Schueller; Barbara A Given
Journal:  Telemed J E Health       Date:  2016-03-16       Impact factor: 3.536

5.  ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.

Authors:  Sarah M Belcher; Emily Mackler; Benyam Muluneh; Pamela K Ginex; Mary K Anderson; Elizabeth Bettencourt; Ryan K DasGupta; Jennifer Elliott; Erica Hall; Michelle Karlin; Diana Kostoff; Victoria K Marshall; Vanessa E Millisor; Maegan Molnar; Susan M Schneider; Janelle Tipton; Susan Yackzan; Kristine B LeFebvre; Kapeena Sivakumaran; Haya Waseem; Rebecca L Morgan
Journal:  Oncol Nurs Forum       Date:  2022-06-17       Impact factor: 1.803

Review 6.  A Concept Analysis of Oral Anticancer Agent Self-management.

Authors:  Madilyn Mason; Marcelline R Harris; Joseph A Greer; Yun Jiang
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

7.  A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer.

Authors:  Kirsti I Toivonen; Linda E Carlson; Joshua A Rash; Tavis S Campbell
Journal:  Patient Prefer Adherence       Date:  2021-09-15       Impact factor: 2.711

8.  Oral self-management of palbociclib (Ibrance®) using mobile technology protocol.

Authors:  Ann M Mazzella Ebstein; Margaret Barton-Burke; Venice Anthony; Andrea Smith; Zhigang Zhang; Mark Robson
Journal:  J Adv Nurs       Date:  2020-11-27       Impact factor: 3.187

9.  Development of a Smartphone Program to Support Adherence to Oral Chemotherapy in People with Cancer.

Authors:  Xiomara Skrabal Ross; Kate M Gunn; Pandora Patterson; Ian Olver
Journal:  Patient Prefer Adherence       Date:  2019-12-20       Impact factor: 2.711

10.  Development of Self-Management Support Program for Elderly Patients with Lung Cancer Receiving Molecularly-Targeted Therapy.

Authors:  Akiko Fukawa
Journal:  Asia Pac J Oncol Nurs       Date:  2021-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.